Developing an Intervention to Address Suicide Risk During Substance Use Disorder

NCT01127932 | Completed

• 1 other identifier: 5R21DA026925-02
• Study Type: interventional
• Target: 56
• Locations: 1 country
• Sites: 1

Brief Summary

This is a 2-year study designed to: (1) adapt and refine an existing cognitive-behavioral treatment (CBT) intervention to decrease suicidal thoughts and behaviors for use in Substance Use Disorder (SUD) treatment settings, and (2) conduct a pilot randomized controlled trial with 50 patients in treatment for SUDs comparing the CBT intervention to an enhanced control condition. Through this pilot randomized controlled trial, the investigators hope to not only obtain information about the feasibility of implementing these procedures in residential SUD treatment, but to also determine whether this intervention decreases the level of suicidal ideation, suicide attempts, hopelessness, and frequency of substance use relative to the control condition.

Conditions

Suicide; Substance-Related Disorders

Keywords

Cognitive Behavioral Therapy

Outcome Measures

Primary Outcomes (1)

• Level of Suicidal Ideation

  Six months

Study Arms (2)

CBT for suicide

EXPERIMENTAL

Behavioral: CBT for suicide in Substance abuse

Enhanced care control group

ACTIVE COMPARATOR

This group is designed to be an active control which provides detailed information about substance use, suicide risk, and depression without providing any CBT or other specific therapy.

Behavioral: Psychoeducation for substance abuse

Interventions

Psychoeducation for substance abuse BEHAVIORAL

This active control provides detailed information about substance use, suicide risk, and depression to those enrolled.

Enhanced care control group

CBT for suicide in Substance abuse BEHAVIORAL

The therapeutic intervention group is designed to provide beneficial coping strategies that are helpful in dealing with both substance use and suicidal thoughts.

CBT for suicide

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Must be over 18 years of age
• Report a past lifetime suicide attempt
• Report current suicidal ideation
• Resided in treatment for less than 4 weeks
• In treatment for less than 6 months

You may not qualify if:

• Mental incompetence (e.g. unable to provide informed consent)
• Diagnosis of schizophrenia or currently psychotic

Sponsors & Collaborators

• University of Michigan: lead
• National Institute on Drug Abuse (NIDA): collaborator

Study Sites (1)

Community Programs, INC.

Waterford, Michigan, 48327, United States

Location

MeSH Terms

Conditions

Suicide; Substance-Related Disorders

Condition Hierarchy (Ancestors)

Self-Injurious Behavior; Behavioral Symptoms; Behavior; Chemically-Induced Disorders; Mental Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor of Psychiatry

Study Record Dates

• First Submitted: May 20, 2010
• First Posted: May 21, 2010
• Study Start: April 1, 2010
• Primary Completion: July 1, 2011
• Study Completion: September 1, 2011
• Last Updated: May 13, 2015

Record last verified: 2015-05

Locations

US (1)